Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain

Journal of Clinical Oncology

Volumn 16, Issue 10, 1998, Pages 3230-3237

  Kaplan, Ronald ^a   Parris, Winston C ^a   Citron, Marc L ^a   Zhukovsky, Donna ^a   Reder, Robert F ^a   Buckley, Barbara J ^a   Kaiko, Robert F ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYCODONE;

ADULT; ARTICLE; CANCER PAIN; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED DRUG RELEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROTOXICITY; PAIN ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; TABLET FORMULATION;

EID: 0031752908     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.10.3230     Document Type: Article

References (29)

1. Jacox A, Carr DB, Payne R, et al: Management of Cancer Pain: Clinical Practice Guideline No. 9. Rockville, MD, Agency for Health Care Policy and Research (AHCPR), Department of Health and Human Services, Public Health Service, 1994, AHCPR publication no. 94-0592
2. Falk E: Eukodal, ein neues narkotikum. Muench Med Wochenschrift 12:381-384, 1917
3. O'Brien CP: Drug addiction and drug abuse, in Hardman JG, Limbird LE, Molinoff PB, et al (eds): Goodman & Gilman's The Pharmacological Basis of Therapeutics (ed 9). New York, NY, McGraw-Hill, 1996, pp 557-577
4. Reisine T, Pasternak G: Opioid analgesics and antagonists, in Hardman JG, Limbird LE, Molinoff PB, et al (eds): Goodman & Gilman's The Pharmacological Basis of Therapeutics (ed 9). New York, NY, McGraw-Hill, 1996, pp 521-555
5. WHO: Cancer Pain Relief: With a Guide to Opioid Availability (ed 2). Geneva, Switzerland, World Health Organization, 1996
6. Beaver WT: Aspirin and acetaminophen as constituents of analgesic combinations. Arch Intern Med 141:293-300, 1981
7. Glare PA, Walsh TD: Dose-ranging study of oxycodone for chronic pain in advanced cancer. J Clin Oncol 11:973-978, 1993
8. Pöyhiä R, Vainio A, Kalso E: A review of oxycodone's clinical pharmacokinetics and pharmacodynamics. J Pain Symptom Manage 8:63-67, 1993
9. Reder RF, Oshlack B, Miotto JB, et al: Steady-state bioavailability of controlled-release oxycodone in normal subjects. Clin Ther 18:95-105, 1996
10. Mandema JW, Kaiko RF, Oshlack B, et al: Characterization and validation of a pharmacokinetic model for controlled-release oxycodone. Br J Clin Pharmacol 42:747-756, 1996
11. Sunshine A, Olson NZ, Colon A, et al: Analgesic efficacy of controlled-release oxycodone in postoperative pain. J Clin Pharmacol 36:595-603, 1996
12. Foley KM: The treatment of cancer pain. N Engl J Med 313:84-95, 1985
13. Houde RW: The use and misuse of narcotics in the treatment of chronic pain. Adv Neurol 4:527-536, 1974
14. Wallenstein SL: Scaling clinical pain and pain relief, in Bromm B (ed): Pain Measurement in Man: Neurophysiological Correlates of Pain. Amsterdam, the Netherlands, Elsevier Science, 1984, pp 389-396
15. Collins SL, Moore RA, McQuay HJ: The visual analogue pain intensity scale: What is moderate pain in millimetres? Pain 72:95-97, 1997
16. Ohnhaus EE, Adler R: Methodological problems in the measurement of pain: A comparison between the verbal rating scale and the visual analog scale. Pain 1:379-384, 1975
17. Jensen MP, Karoly P: Self-report scales and procedures for assessing pain in adults, in Turk DC, Melzack R (eds): Handbook of Pain Assessment. New York, NY, Guilford, 1992, pp 135-151
18. Downie WW, Leatham PA, Rhind VM, et al: Studies with pain rating scales. Ann Rheum Dis 37:378-381, 1978
19. Littman GS, Walker BR, Schneider BE: Reassessment of verbal and visual analog ratings in analgesic studies. Clin Pharmacol Ther 38:16-23, 1985
20. Preston KL, Jasinski DR, Testa M: Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alcohol Depend 27:7-17, 1991
21. Kaiko RF, Benziger DP, Fitzmartin RD, et al: Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone. Clin Pharmacol Ther 59:52-61, 1996
22. American Pain Society: Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain (ed 3). Skokie, IL, American Pain Society, 1992, pp 10-27
23. Kalso E, Vainio A: Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther 47:639-646, 1990
24. Watson CPN, Babul N: Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia. Neurology 50:1837-1841, 1998
25. Max MB: Divergent traditions in analgesic clinical trials. Clin Pharmacol Ther 56:237-241, 1994
26. Marshall H, Porteous C, McMillan I, et al: Relief of pain by infusion of morphine after operation: Does tolerance develop? Br Med J 291:19-21, 1985
27. Paalzow LK: Pharmacokinetic/pharmacodynamic aspects of controlled release products. Presented at the Swedish Academy of Pharmaceutical Sciences FIP-Satellite Symposium on Optimizing Therapy Using Controlled Release Products, Stockholm, Sweden, August 25-26, 1995
28. Lapin J, Houde RW, Kaiko RF, et al: Cancer pain management with a controlled-release oral morphine preparation. J Pain Symptom Manage 4:146-151, 1989
29. Citron ML, Kaplan R, Parris WCV, et al: Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain. Cancer Invest 16:562-571, 1998